{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T06:16:45Z","timestamp":1788675405954,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,10]]},"DOI":"10.7759\/cureus.78803","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:31:51Z","timestamp":1739176311000},"source":"Crossref","is-referenced-by-count":3,"title":["Prolonged Elimination of Lamotrigine After Suicidal Overdose: A Case Report"],"prefix":"10.7759","author":[{"given":"Hiroshi","family":"Mae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuho","family":"Namiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munekazu","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-016-0148-6","article-title":"An updated overview on therapeutic drug monitoring of recent antiepileptic drugs","volume":"16","author":"Jacob S","year":"2016","unstructured":"Jacob S, Nair AB. An updated overview on therapeutic drug monitoring of recent antiepileptic drugs. Drugs R D. 2016, 16:303-16. 10.1007\/s40268-016-0148-6","journal-title":"Drugs R D"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12984","article-title":"Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: influence of polymorphism of UDP-glucuronosyltransferases and drug transporters","volume":"82","author":"Milosheska D","year":"2016","unstructured":"Milosheska D, Lorber B, Vovk T, Kastelic M, Dol\u017ean V, Grabnar I. Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide: influence of polymorphism of UDP-glucuronosyltransferases and drug transporters. Br J Clin Pharmacol. 2016, 82:399-411. 10.1111\/bcp.12984","journal-title":"Br J Clin Pharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2017.1370096","article-title":"Acute lamotrigine overdose: a systematic review of published adult and pediatric cases","volume":"56","author":"Alyahya B","year":"2018","unstructured":"Alyahya B, Friesen M, Nauche B, Lalibert\u00e9 M. Acute lamotrigine overdose: a systematic review of published adult and pediatric cases. Clin Toxicol (Phila). 2018, 56:81-9. 10.1080\/15563650.2017.1370096","journal-title":"Clin Toxicol (Phila)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(91)90012-5","article-title":"Pharmacokinetics and safety of lamotrigine (Lamictal\u00ae) in patients with epilepsy","volume":"10","author":"Ramsay RE","year":"1991","unstructured":"Ramsay RE, Pellock JM, Garnett WR, et al.. Pharmacokinetics and safety of lamotrigine (Lamictal\u00ae) in patients with epilepsy. Epilepsy Res. 1991, 10:191-200. 10.1016\/0920-1211(91)90012-5","journal-title":"Epilepsy Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2.6.1009","article-title":"Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy","volume":"2","author":"Biton V","year":"2006","unstructured":"Biton V. Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy. Expert Opin Drug Metab Toxicol. 2006, 2:1009-18. 10.1517\/17425255.2.6.1009","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199120060-00001","article-title":"Nonlinear pharmacokinetics: clinical implications","volume":"20","author":"Ludden TM","year":"1991","unstructured":"Ludden TM. Nonlinear pharmacokinetics: clinical implications. Clin Pharmacokinet. 1991, 20:429-46. 10.2165\/00003088-199120060-00001","journal-title":"Clin Pharmacokinet"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000570","article-title":"Fundamental pharmacokinetic concepts and their clinical relevance: clearance, zero versus first order and nonlinear pharmacokinetics","volume":"27","author":"Preskorn SH","year":"2021","unstructured":"Preskorn SH. Fundamental pharmacokinetic concepts and their clinical relevance: clearance, zero versus first order and nonlinear pharmacokinetics. J Psychiatr Pract. 2021, 27:380-3. 10.1097\/PRA.0000000000000570","journal-title":"J Psychiatr Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1998.00769.x","article-title":"Therapeutic drug monitoring--antiepileptic drugs","volume":"46","author":"Eadie MJ","year":"1998","unstructured":"Eadie MJ. Therapeutic drug monitoring--antiepileptic drugs. Br J Clin Pharmacol. 1998, 46:185-93. 10.1046\/j.1365-2125.1998.00769.x","journal-title":"Br J Clin Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2011.03217.x","article-title":"The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy","volume":"52","author":"Arif H","year":"2011","unstructured":"Arif H, Svoronos A, Resor SR Jr, Buchsbaum R, Hirsch LJ. The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy. Epilepsia. 2011, 52:1905-13. 10.1111\/j.1528-1167.2011.03217.x","journal-title":"Epilepsia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000172","article-title":"Therapeutic index estimation of antiepileptic drugs: a systematic literature review approach","volume":"39","author":"Greenberg RG","year":"2016","unstructured":"Greenberg RG, Melloni C, Wu H, et al.. Therapeutic index estimation of antiepileptic drugs: a systematic literature review approach. Clin Neuropharmacol. 2016, 39:232-40. 10.1097\/WNF.0000000000000172","journal-title":"Clin Neuropharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.572555","article-title":"Complete heart block and death following lamotrigine overdose","volume":"49","author":"French LK","year":"2011","unstructured":"French LK, McKeown NJ, Hendrickson RG. Complete heart block and death following lamotrigine overdose. Clin Toxicol (Phila). 2011, 49:330-3. 10.3109\/15563650.2011.572555","journal-title":"Clin Toxicol (Phila)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3109\/15563650.2011.617307","article-title":"Severe sodium channel blockade and cardiovascular collapse due to a massive lamotrigine overdose","volume":"49","author":"Nogar JN","year":"2011","unstructured":"Nogar JN, Minns AB, Savaser DJ, Ly BT. Severe sodium channel blockade and cardiovascular collapse due to a massive lamotrigine overdose. Clin Toxicol (Phila). 2011, 49:854-7. 10.3109\/15563650.2011.617307","journal-title":"Clin Toxicol (Phila)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2007.06.004","article-title":"Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine","volume":"51","author":"Sirianni AJ","year":"2008","unstructured":"Sirianni AJ, Osterhoudt KC, Calello DP, et al.. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008, 51:412-5. 10.1016\/j.annemergmed.2007.06.004","journal-title":"Ann Emerg Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.0420081082.x","article-title":"Stupor from lamotrigine toxicity","volume":"42","author":"Sbei M","year":"2001","unstructured":"Sbei M, Campellone JV. Stupor from lamotrigine toxicity. Epilepsia. 2001, 42:1082-3. 10.1046\/j.1528-1157.2001.0420081082.x","journal-title":"Epilepsia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.22037\/ijpr.2015.1749","article-title":"Report of severe menorrhagia following the maximum amount of lamotrigine overdose","volume":"14","author":"Hajiali F","year":"2015","unstructured":"Hajiali F, Nassiri-Asl M. Report of severe menorrhagia following the maximum amount of lamotrigine overdose. Iran J Pharm Res. 2015, 14:1289-93. 10.22037\/ijpr.2015.1749","journal-title":"Iran J Pharm Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1991.tb05883.x","article-title":"Clinical pharmacology of lamotrigine","volume":"32","author":"Peck AW","year":"1991","unstructured":"Peck AW. Clinical pharmacology of lamotrigine. Epilepsia. 1991, 32:S9-12. 10.1111\/j.1528-1157.1991.tb05883.x","journal-title":"Epilepsia"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2018.01.011","article-title":"UGT polymorphisms and lamotrigine clearance during pregnancy","volume":"140","author":"Petrenaite V","year":"2018","unstructured":"Petrenaite V, \u00d6hman I, Ekstr\u00f6m L, S\u00e6bye D, Hansen TF, Tomson T, Sabers A. UGT polymorphisms and lamotrigine clearance during pregnancy. Epilepsy Res. 2018, 140:199-208. 10.1016\/j.eplepsyres.2018.01.011","journal-title":"Epilepsy Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.29","article-title":"Model-based lamotrigine clearance changes during pregnancy: clinical implication","volume":"1","author":"Polepally AR","year":"2014","unstructured":"Polepally AR, Pennell PB, Brundage RC, et al.. Model-based lamotrigine clearance changes during pregnancy: clinical implication. Ann Clin Transl Neurol. 2014, 1:99-106. 10.1002\/acn3.29","journal-title":"Ann Clin Transl Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2019.05.026","article-title":"Management of lamotrigine overdose using hemodialysis","volume":"37","author":"Agrawal A","year":"2019","unstructured":"Agrawal A, Nogar JN, Koenig S. Management of lamotrigine overdose using hemodialysis. Am J Emerg Med. 2019, 37:1603.e1-2. 10.1016\/j.ajem.2019.05.026","journal-title":"Am J Emerg Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2010.11.055","article-title":"Lipid emulsion as rescue therapy in lamotrigine overdose","volume":"42","author":"Castanares-Zapatero D","year":"2012","unstructured":"Castanares-Zapatero D, Wittebole X, Huberlant V, Morunglav M, Hantson P. Lipid emulsion as rescue therapy in lamotrigine overdose. J Emerg Med. 2012, 42:48-51. 10.1016\/j.jemermed.2010.11.055","journal-title":"J Emerg Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4103\/sjg.sjg_406_21","article-title":"N-acetylcysteine for non-acetaminophen induced acute liver failure: a review","volume":"28","author":"Jiang SX","year":"2022","unstructured":"Jiang SX, Hussaini T, Yoshida EM. N-acetylcysteine for non-acetaminophen induced acute liver failure: a review. Saudi J Gastroenterol. 2022, 28:85-91. 10.4103\/sjg.sjg_406_21","journal-title":"Saudi J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/335435-prolonged-elimination-of-lamotrigine-after-suicidal-overdose-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T08:31:54Z","timestamp":1739176314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/335435-prolonged-elimination-of-lamotrigine-after-suicidal-overdose-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.78803","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}